Ondine Biomedical Inc.
OBI.L · LSE
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£6,359 | -£7,818 | -£6,443 | -£7,971 |
| Dep. & Amort. | £158 | £286 | £279 | £308 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £0 | £0 | £0 | £0 |
| Change in WC | £1,062 | £19 | £809 | -£1,105 |
| Other Non-Cash | £566 | £378 | £87 | £2,180 |
| Operating Cash Flow | -£4,573 | -£7,135 | -£5,268 | -£8,247 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | £0 | -£10 | £0 | -£176 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £0 | £0 | £0 | £0 |
| Investing Cash Flow | £0 | -£10 | £0 | -£176 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | £0 | £0 |
| Stock Issued | £8,608 | £5,549 | £4,168 | £0 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £516 | £5,323 | £3,958 | -£213 |
| Financing Cash Flow | £9,124 | £5,323 | £3,958 | -£213 |
| Forex Effect | £167 | £0 | £0 | -£448 |
| Net Chg. in Cash | £4,719 | -£1,860 | -£1,440 | -£9,084 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £792 | £3,231 | £4,568 | £13,656 |
| End Cash | £5,511 | £1,371 | £3,128 | £4,572 |
| Free Cash Flow | -£4,573 | -£7,145 | -£5,268 | -£8,423 |